Hibiclens is an antimicrobial/antiseptic cleanser that kills germs on contact and bonds with the skin to keep killing microorganisms for up to six hours without leaving a residue. The same cleanser combined with alcohol is available in convenient Hibistat(R) towelettes. Both are available at drug stores and pharmacies in the first aid section. For more information about Hibiclens, Hibistat or CHG, visit www.hibigeebies.com.
About Molnlycke Health Care US, LLC
Molnlycke Health Care US, LLC, consists of two divisions - Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division (formerly Regent Medical Americas, LLC) encompasses the world's leading manufacturer and supplier of powder-free surgical gloves (Biogel(R) surgical gloves); the number one supplier (by value) of skin cleanser (Hibiclens(R) and Hibistat(R) antiseptics); and BARRIER(R) protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment.
'/>"/>SOURCE Molnlycke Health Care Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine technology :1.
Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report2.
Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro)3.
Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques4.
Resurgent Health and Medical Announces That Childrens Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems5.
MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.6.
CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model7.
Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 20088.
Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development9.
DuPont Provides Technology for Washington Hospital Centers Emergency Department10.
Top Washington Health Officials to Honor Framingham Heart Study Participants11.
Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)